Suppr超能文献

检测环磷酰胺在大鼠移植宿主反应(PLNA-GvHR)改良中对腘窝淋巴结试验的免疫抑制作用。

Testing the immunosuppressive effects of cyclophosphamide in the popliteal lymph node assay in the modification of graft-vs-host reaction (PLNA-GvHR) in the rat.

机构信息

The Nofer Institute of Occupational Medicine, 8 Teresy Str, 90-950 Łódź, P.O. Box 199, Poland.

出版信息

Toxicol Mech Methods. 2004;14(6):367-73. doi: 10.1080/15376520490434674.

Abstract

We tested the hypothesis that popliteal lymph node assay (PLNA) in the modification of graft vs host reaction (GvHR) enabled to assess immunosuppressive potential of xenobiotics. We conducted PLNA in GvHR modification under two experimental conditions using cyclophosphamide (CY). In the first experiment average lymph node weight index (IW, weight ratio of popliteal lymph node of hind footpad injected with parental lymphocytes to lymph node of footpad injected with vehicle) in rats administered intraperitoneally with CY simultaneously with, or 3 days before local GvHR induction was 84% and 42%, respectively less than average IW in external control animals injected with parental lymphocytes into one footpad and vehicle into contralateral footpad. Average lymph node lymphocyte index (IL, ratio of cell number in the lymph node undergoing GvHR to control lymph node) in the tested animals was 92% and 86%, respectively less than in controls. In the second experiment in rats injected subcutaneously into one footpad with parental lymphocytes suspended in solution of CY at the concentrations of 4.6 mM or 18.6 mM and with parental lymphocytes into contralateral footpad, average IW was 88%and 92%, respectively less than average IW in the external control animals injected with parental lymphocytes into both footpads (average IL was 84 and 91%, respectively less than in controls). Our preliminary experiments showed a strong inhibitory effect of CY in both PLNA-GvHR models used and we believe that both models may be of value in designing future protocols aiming at prediction of immunosuppressive potential of chemicals.

摘要

我们检验了这样一个假设,即改良移植物抗宿主反应(GvHR)中的腘窝淋巴结检测(PLNA)可用于评估异源物的免疫抑制潜力。我们在两种实验条件下使用环磷酰胺(CY)进行了改良 GvHR 中的 PLNA。在第一个实验中,与局部 GvHR 诱导同时或 3 天前经腹腔给予 CY 的大鼠,其接受亲代淋巴细胞注射的后脚掌垫的淋巴结重量指数(IW,接受亲代淋巴细胞注射的后脚掌垫的淋巴结重量与接受载体注射的脚掌垫的淋巴结重量之比)分别为 84%和 42%,低于接受亲代淋巴细胞注射于一只脚掌垫和载体注射于对侧脚掌垫的外部对照动物的平均 IW。在接受测试的动物中,接受 GvHR 的淋巴结中的淋巴细胞指数(IL,接受 GvHR 的淋巴结中的细胞数与对照淋巴结中的细胞数之比)分别为 92%和 86%,低于对照动物。在第二个实验中,将亲代淋巴细胞混悬液以 4.6mM 或 18.6mM 的浓度皮下注射到一只脚掌垫中,并将亲代淋巴细胞注射到对侧脚掌垫中,接受测试的大鼠的平均 IW 分别为 88%和 92%,低于接受亲代淋巴细胞注射于两只脚掌垫的外部对照动物的平均 IW(平均 IL 分别为 84%和 91%,低于对照)。我们的初步实验显示,CY 在两种使用的 PLNA-GvHR 模型中均具有强烈的抑制作用,我们认为这两种模型都可能对设计未来旨在预测化学物质免疫抑制潜力的方案具有价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验